ArticleCurrent microbiology2025
Inhibitory Effect of Staphylococcus Epidermidis Fermentation Broth on Staphylococcus Aureus.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, Staphylococcus epidermidis (S. epidermidis) fermentation broth with an inhibitory effect on Staphylococcus aureus (S. aureus) was produced by optimizing cultivation conditions. S. epidermidis fermentation broth cultivated in NA medium (SFB) does not inhibit the growth of S. aureus, whereas Gly-SFB or Glu-SFB, prepared by incorporating glycerol or glucose into NA medium, significantly inhibited S. aureus growth. GC‒MS and HPLC revealed several fatty acids in Gly-SFB and Glu-SFB, which inhibited the growth of S. aureus. LC‒MS/MS combined with untargeted metabolomics was used to examine the differentially abundant metabolites in the fermentation broth. The results revealed that the main differentially abundant metabolites of the fermentation broths were carboxylic acids and their derivatives, which included peptides containing lysine, arginine, and hydrophobic amino acid residues, which may be the principal compounds that inhibit the growth of S. aureus in the fermentation broth. Scanning Electron Microscope (SEM) and Propidium iodide (PI) staining results indicated that the cell membrane of S. aureus was compromised following treatment with Gly-SFB or Glu-SFB, significantly increasing the extracellular ATP levels of S. aureus. The dependence on carbon sources altered the metabolic pathway of S. epidermidis, resulting in the growth suppression of S. aureus by Gly-SFB and Glu-SFB. The inhibitory effect mostly relies on the presence of fatty acids in the fermentation broth and the synergistic interactions among other compounds.
Indexed as
Identifiers
41251821What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.